Dexamethasone Sodium Phosphate Injection — FDA Drug Shortage

Current — Somerset Therapeutics, LLC

The FDA lists a drug shortage record for Dexamethasone Sodium Phosphate Injection (injection) from Somerset Therapeutics, LLC with status Current. The shortage was first posted on 02/08/2019.

Shortage Details

Status
Current
Company
Somerset Therapeutics, LLC
Package NDC
70069-025-10
Dosage Form
Injection
Presentation
Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 70069-025-10)
Initial Posting
02/08/2019
Revised Date